Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease
Por:
Tovar-Palacio C., Noriega L.G., Mercado A.
Publicada:
1 ene 2022
Resumen:
SIRT1 is an NAD+-dependent class III histone deacetylase that is abundantly expressed in the kidney, where it modulates gene expression, apoptosis, energy homeostasis, autophagy, acute stress responses, and mitochondrial biogenesis. Alterations in SIRT1 activity and NAD+ metabolism are frequently observed in acute and chronic kidney diseases of diverse origins, including obesity and diabetes. Nevertheless, in vitro and in vivo studies and clinical trials with humans show that the SIRT1-activating compounds derived from natural sources, such as polyphenols found in fruits, vegetables, and plants, including resveratrol, quercetin, and isoflavones, can prevent disease and be part of treatments for a wide variety of diseases. Here, we summarize the roles of SIRT1 and NAD+ metabolism in renal pathophysiology and provide an overview of polyphenols that have the potential to restore SIRT1 and NAD+ metabolism in renal diseases. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Filiaciones:
Tovar-Palacio C.:
Dirección de Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, 14080, Mexico
Noriega L.G.:
Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, 14080, Mexico
Mercado A.:
Laboratorio de Biología Molecular, Departamento de Nefrología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, 14080, Mexico
Gold
|